SARS-CoV-2 reprograms murine alveolar macrophages to dampen flu DOI
Alexandra Tabachnikova, Akiko Iwasaki

Trends in Immunology, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 1, 2024

Language: Английский

Prevalence and risk factors for long COVID in China: a systematic review and meta-analysis of observational studies DOI Creative Commons

Le-Yan Hu,

A. Cai,

Bo Li

et al.

Journal of Infection and Public Health, Journal Year: 2025, Volume and Issue: 18(3), P. 102652 - 102652

Published: Jan. 5, 2025

With the outbreak of COVID-19 in China, a large number patients are at risk long COVID after recovery. The purpose our research is to systematically review existing clinical studies understand current prevalence and related factors China. protocol this systematic was registered on PROSPERO (CRD42024519375). We searched six electronic databases from 1st January 2020-1st March 2024. Literature screening, data extraction, bias assessment were independently carried out by two reviewers. Quality included evaluated AHRQ NOS. meta-analysis performed R software 4.2.3 derive factors. Overall, 50 with 65880 participants included. results showed that (with least one symptom) among approximately % (95 %Confidence Interval (CI) 42-58 %) Although we conducted meta-regression subgroup analysis, heterogeneity study high. But Omicron BA.2 variant had statistically significant effect (P = 0.0004). three most common symptoms fatigue (0.33, 95 %CI 0.28-0.39), cognitive decline (0.30, 0.14-0.46) shortness breath (0.29, 0.15-0.43). Patients severe acute phase (Odds Ratio (OR) 1.57, CI 1.39-1.77), combined 2 comorbidities (OR 1.80, 1.40-2.32), 3 2.13, 1.64-2.77), advanced age 1.02, 1.01-1.04), female 1.58, 1.44-1.73) for prevalence. Current found nearly half may suffering Establishing recovery-support platform regular follow-up would help long-term monitor manage patients, especially those high-risk population.

Language: Английский

Citations

1

Rates of infection with other pathogens after a positive COVID-19 test versus a negative test in US veterans (November, 2021, to December, 2023): a retrospective cohort study DOI
Miao Cai, Evan Xu, Yan Xie

et al.

The Lancet Infectious Diseases, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Language: Английский

Citations

1

Long-term trends in the prevalence of cardiovascular-kidney-metabolic syndrome in South Korea, 2011–2021: a representative longitudinal serial study DOI Creative Commons

Yesol Yim,

Jae Eun Lee, Yejun Son

et al.

The Lancet Regional Health - Western Pacific, Journal Year: 2025, Volume and Issue: 55, P. 101474 - 101474

Published: Jan. 22, 2025

Language: Английский

Citations

0

Enduring Coagulopathy and Endothelial Dysfunction in Post-Acute COVID-19 Syndrome (PACS): A One-Year Longitudinal Cohort Study DOI
Yucan Li,

Tichao Shan,

Zhengqi Jiang

et al.

Published: Jan. 1, 2025

Language: Английский

Citations

0

Disruption and adaptation: infant gut microbiota’s dynamic response to SARS-CoV-2 infection DOI Creative Commons
Liting Zhu, Lei Zhao,

Yue Zhu

et al.

Microbiome, Journal Year: 2025, Volume and Issue: 13(1)

Published: March 11, 2025

The responses of the infant gut microbiota to infection significantly disrupt natural intrahost evolutionary processes microbiome. Here, we collected a 16-month longitudinal cohort microbiomes affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Then, developed multicriteria approach identify core interaction network driving community dynamics under environmental disturbances, which termed Conserved Variated Interaction Group (CVIgroup). CVIgroup showed significant advantages on pinpointing sparse set associated with as validated both our own and publicly available datasets. Leveraging Oxford Nanopore Technology, found this group facilitates ecosystem's adaptation disruptions enhancing mobility mobile genetic elements, including reinforcement twin-arginine translocation pathway in response increased virulence factors. Furthermore, serves an effective indicator ecosystem health. timescale for microbiota's extends beyond 10 months. Members CVIgroup, such Bacteroides thetaiotaomicron Faecalibacterium, exhibit varying degrees genomic structural variants, contribute guiding toward new stable state rather than returning its original configuration. Collectively, offers snapshot adaptive disturbances. disruption subsequent infants after COVID-19 underscores necessity re-evaluating reference standards context post-pandemic era.

Language: Английский

Citations

0

Viral persistence in long COVID: Research advances and treatment strategies DOI Creative Commons
Shiyang Liu, Yuming Guo, Fu‐Sheng Wang

et al.

Infectious Diseases & Immunity, Journal Year: 2025, Volume and Issue: unknown

Published: April 28, 2025

Abstract Although the coronavirus disease 2019 (COVID-19) pandemic has ended, enduring health impacts of severe acute respiratory syndrome 2 (SARS-CoV-2) infection continue to garner global attention, as approximately 10% patients develop long COVID (post COVID-19 condition). The epidemiological characteristics and symptoms have been reported, various pathogenic hypotheses proposed. Recent evidence suggests that SARS-CoV-2 nucleic acids or fragments persist in some post-infection these are correlated with symptoms. This review focuses on clinical studies linking persistence symptoms, explores relationship between viral other etiological hypotheses, such immune dysregulation, vascular issues, coagulation dysfunction, microbiome dysbiosis, brainstem/vagus nerve signaling latent virus reactivation. Futhermore, treatment strategies for proposed based current trials antiviral modulation therapies. Understanding role pathogenesis is critical developing targeted therapies improving management this debilitating condition.

Language: Английский

Citations

0

Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19 DOI Creative Commons

Emi E. Nakayama,

Tatsuo Shioda

Pathogens, Journal Year: 2024, Volume and Issue: 13(12), P. 1109 - 1109

Published: Dec. 15, 2024

Antibody-dependent enhancement (ADE) is a phenomenon in which antibodies enhance subsequent viral infections rather than preventing them. Sub-optimal levels of neutralizing individuals infected with dengue virus are known to be associated severe disease upon reinfection different serotype. For Severe Acute Respiratory Syndrome Coronavirus type-2 infection, three types ADE have been proposed: (1) Fc receptor-dependent infection cells expressing receptors, such as macrophages by anti-spike antibodies, (2) receptor-independent epithelial and (3) cytokine production anti-nucleocapsid antibodies. This review focuses on the induced examining its potential role COVID-19 during contribution post-acute sequelae COVID-19, i.e., prolonged symptoms lasting at least months after acute phase disease. We also discuss protective effects recently identified that neutralize Omicron variants.

Language: Английский

Citations

2

Long Covid is a significant health crisis in China too DOI Creative Commons
Ziyad Al‐Aly

The Lancet Regional Health - Western Pacific, Journal Year: 2024, Volume and Issue: 52, P. 101223 - 101223

Published: Oct. 14, 2024

Language: Английский

Citations

1

SARS-CoV-2 reprograms murine alveolar macrophages to dampen flu DOI
Alexandra Tabachnikova, Akiko Iwasaki

Trends in Immunology, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 1, 2024

Language: Английский

Citations

1